We are live on ! Find out more
AKRO

Akero Therapeutics
AKRO

Delisted

AKRO was delisted on the 8th of December, 2025.

Back to rankings

109 hedge funds and large institutions have $913M invested in Akero Therapeutics in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

16% more funds holding

Funds holding: 94 → 109 (+15)

12% more capital invested

Capital invested by funds: $814M → $913M (+$99.7M)

1.78% more ownership

Funds ownership: 88.84% → 90.62% (+1.8%)

6% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 31

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

91% less call options, than puts

Call options by funds: $2.23M | Put options by funds: $24.5M

Holders
109
Holders Change
+15
Holders Change %
+15.96%
% of All Funds
1.91%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
24
Increased
29
Reduced
31
Closed
9
Calls
$2.23M
Puts
$24.5M
Net Calls
-$22.3M
Net Calls Change
-$21.1M

Top Buyers

Rank Fund Capital Flow
1
YCM
Yiheng Capital Management
California
+$8.12M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$7.13M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.32M
4
Alkeon Capital Management
Alkeon Capital Management
New York
+$6.3M
5
RG
Redmile Group
California
+$5.79M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.01M
2
Millennium Management
Millennium Management
New York
-$5.42M
3
VVM
Versant Venture Management
California
-$4.84M
4
Renaissance Technologies
Renaissance Technologies
New York
-$3.87M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$3.43M – – –
Charles Schwab
27
Charles Schwab
California
$3.22M +$96.2K +3,179 +3%
MWNA
28
Marshall Wace North America
New York
$2.5M -$2.08M -68,565 -44%
Millennium Management
29
Millennium Management
New York
$2.48M -$5.42M -178,919 -68%
IHAM
30
Integral Health Asset Management
New York
$2.47M – – –
CS
31
Candriam SCA
Luxembourg
$2.39M – – –
Simplex Trading
32
Simplex Trading
Illinois
$1.97M +$2.06M +68,063 New
AA
33
ALPS Advisors
Colorado
$1.82M +$2.79K +92 +0.1%
Citigroup
34
Citigroup
New York
$1.74M +$1.69M +55,762 +1,277%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.58M -$169K -5,584 -9%
N
36
Nuveen
North Carolina
$1.46M -$28.4K -939 -2%
JP Morgan Chase
37
JP Morgan Chase
New York
$1.39M +$45.1K +1,491 +3%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$1.37M +$1.16M +38,448 +436%
Group One Trading
39
Group One Trading
Illinois
$1.27M +$1.33M +43,819 +66,392%
Aviva
40
Aviva
United Kingdom
$1.16M +$1.21M +39,880 New
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.02M – – –
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$948K -$504K -16,640 -34%
SCM
43
Silverarc Capital Management
Massachusetts
$928K -$96.2K -3,179 -9%
CPIG
44
Chicago Partners Investment Group
Illinois
$912K – – –
Morgan Stanley
45
Morgan Stanley
New York
$876K +$42.5K +1,404 +5%
Deutsche Bank
46
Deutsche Bank
Germany
$874K -$1.09M -35,926 -54%
UBS Group
47
UBS Group
Switzerland
$830K +$680K +22,455 +365%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$798K -$76.6K -2,529 -8%
Ensign Peak Advisors
49
Ensign Peak Advisors
Utah
$733K – – –
TD Asset Management
50
TD Asset Management
Ontario, Canada
$728K +$166K +5,497 +28%
1
2
3 4 5

AKRO Hedge Fund Activity: Q1 2021 in Review

109 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Akero Therapeutics (AKRO) for Q1 2021, worth a combined $913M — up 12% from $814M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AKRO positions and 9 closed out — a net gain of 15 holders — while 29 added to existing stakes and 31 trimmed.

The largest buyer was Yiheng Capital Management, opening a new position worth an estimated $8.12M. The largest seller was Point72 Asset Management, cutting an estimated $6.01M.

  • 109 institutional investors held Akero Therapeutics (AKRO) as of Q1 2021, up from 94 in Q4 2020.
  • Funds reported $913M of Akero Therapeutics stock for Q1 2021, up 12% quarter-over-quarter.
  • 24 funds opened new Akero Therapeutics positions in Q1 2021 and 9 closed out, a net change of +15 holders.
  • The largest Akero Therapeutics buyer in Q1 2021 was Yiheng Capital Management, an estimated $8.12M added.
  • The largest Akero Therapeutics seller in Q1 2021 was Point72 Asset Management, an estimated $6.01M sold.

Based on aggregated 13F filings for Q1 2021.